NMRA icon

Neumora Therapeutics
NMRA

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$8
157% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
William Blair
William Blair
Myles Minter
0% 1-yr NMRA win rate
17 Feb ‘26 15 days ago
Leerink Partners
Leerink Partners
Marc Goodman
100% 1-yr NMRA win rate
12 Jan ‘26 1 month ago